Dr Amy Keir

Brief biography:

Dr Amy Keir is a Consultant Neonatologist at the Women's and Children's Hospital and a MedSTAR kids Retrieval Consultant with the SA Ambulance Service. She is a NHMRC Early Career Fellow focussing on 'Improving outcomes for preterm babies through closing the evidence to practice gap' with SAHMRI Women and Kids and the University of Adelaide.

Qualifications:

Doctor of Philosophy (Medicine) PhD

Fellowship of the Royal Australasian College of Physicians (RACP)

Master in Public Health: Major in Aeromedical Retrieval (MPH)

Bachelor of Medicine/Bachelor of Surgery (MBBS)

Awards/Honours/Scholarships:

Eric Burnard Fellowship, the Royal Australasian College of Physicians (RACP) Foundation

Fellowship in Neonatal-Perinatal Medicine, University of Toronto, Ontario, Canada

Robert F Seamark Scholarship, University of Adelaide

Young Investigator Award Winner, Women’s and Children’s Hospital Foundation

Selected publications:

Hilditch C, Liersch B, Spurrier N, Callander E, Cooper C and Keir AK. Does screening for congenital cytomegalovirus at birth improve longer-term hearing outcomes? Archives of Disease in Childhood 2018. doi:10.1136/archdischild-2017-314404

Hilditch C and Keir A. EBNEO Review: Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection Acta Paediatrica 2018 107(5):906. doi: 10.1111/apa.14212

Valpacos M, Arni D, Keir A, Aspirot A, Wilde K, Beasley S, De Luca D, Pfister RE, Karam O. Diagnosis and Management of Necrotizing Enterocolitis: An International Survey of Neonatologists and Pediatric Surgeons Neonatology 2018 113(2):170-176. doi: 10.1159/000484197

Keir AK, Pal S, Trivella M, Lieberman L, Callum J, Shehata N, Stanworth S. Adverse effects of RBC transfusions in neonates: a systematic review and meta-analysis Transfusion 2016; 56(11): 2773-2780. doi: 10.1111/trf.13785.

Lieberman L, Spradbrow J, Keir AK, Lin Y, Callum J. Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: A retrospective eleven-year study Transfusion 2016; 56(11): 2704-2711. doi: 10.1111/trf.13721.

Keir AK, Wilkinson D, Andersen C, Stark M. Cochrane review: Washed versus unwashed red blood cells for transfusion for the prevention of morbidity and mortality in preterm infants Cochrane Database Syst Rev. 2016; doi: 10.1002/14651858.CD011484

Keir AK, Froessler B, Stanworth S. Are intravenous fluid boluses beneficial in late preterm or term infants with suspected haemodynamic compromise? Archives of Disease in Childhood 2016; 101(2): 201-2. doi:10.1136/archdischild-2015-309182

Andersen CC, Keir AK, Kirpalani HM, Stark MJ. Anaemia in the Premature Infant and Red Blood Cell Transfusion: New Approaches to an Age-Old Problem Current Treatment Options in Pediatrics 2015; doi: 10.1007/s40746-015-0021-9

Kopolovic, I, Ostro, J, Tsubota, H, Lin, Y, Cserti-Gazdewich CM, Messner HA, Keir AK, Den Hollander N, Dzik WS, Callum J. A systematic review of transfusion-associated graft versus host disease (TA-GVHD) Blood 2015; 126(3): 406-14. doi: 10.1182/blood-2015-01-620872

Keir AK, Aziz K, McMillan D, Moterrosa L, Ojah C, Lee S, Shah PS on behalf of the Canadian Neonatal Network. Red blood cell transfusions and outcomes of preterm infants <30 weeks gestational age after 21 days of age American Journal of Perinatology 2015; 32(12): 1139-44. doi: 10.1055/s-0035-1549295.

Keir AK, Yang J, Harrison A, Pelausa E, Shah PS on behalf of the Canadian Neonatal Network. Temporal changes in blood product usage in preterm neonates born at <30 weeks’ gestation in Canada Transfusion 2015; 55(6): 1340-6. doi: 10.1111/trf.12998.

Keir AK, Wilkinson D, Andersen C, Stark M. Washed versus unwashed red blood cells for transfusion for the prevention of morbidity and mortality in preterm infants (Protocol). Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No.: CD011484. doi: 10.1002/14651858.CD011484.

Keir AK, Agpalo M, Lieberman L, Callum J. How to use: the direct antiglobulin test (DAT) in newborns Archives of Disease in Childhood – Education and Practice Education 2014; 00(4):198-203. doi:10.1136/archdischild-2013-305553

Keir A, Pal Sanchita, Trivella M, Lieberman L, Callum J, Shehata N, Stanworth S. Systematic review protocol: Adverse effects of small volume red blood cell transfusions in the neonatal population Systematic Reviews 2014; 3:92. doi:10.1186/2046-4053-3-92

Keir A, Giesinger R, Dunn M. How long should umbilical venous catheters remain in place in infants who require long-term (≥ 5-7 days) central venous access? Journal of Paediatrics and Child Health 2014; 50(8): 649-52. doi: 10.1111/jpc.12690.

Keir A, Hansen A, Jankov R, Callum J, Acker J. Co-infusion of dextrose-containing fluids and red cell concentrates does not adversely affect in-vitro red blood cell quality Transfusion 2014; 54(8): 2068-2076. doi: 10.1111/trf.12618.

Keir A, Dunn M, Callum J. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility? Journal of Paediatrics and Child Health 2013; 49(12):1072-8. doi: 10.1111/jpc.12440